. 2021 Oct 7;21:251. doi: 10.1186/s12906-021-03428-6

Table 6.

Reversion rate to normal cognition as measured using the CDR-GS score after 24 weeks of intervention

CDR	KGT group (n = 16)	Placebo group (n = 14)	p-value^‡
Reversion to normal (CDR of 0.5 points → 0 points)	5 (31.25%)	2 (14.29%)	0.399
Stable MCI (CDR of 0.5 points)	11 (68.75%)	12 (85.71%)
Conversion to dementia (CDR of 0.5 points → ≥1 point)	0 (0%)	0 (0%)

CDR

KGT group (n = 16)

Placebo group (n = 14)

p-value^‡

Reversion to normal

(CDR of 0.5 points → 0 points)

5 (31.25%)

2 (14.29%)

0.399

Stable MCI

(CDR of 0.5 points)

11 (68.75%)

12 (85.71%)

Conversion to dementia

(CDR of 0.5 points → ≥1 point)

0 (0%)

CDR-GS, Clinical Dementia Rating-Global Score; KGT, Kami-guibi-tang; MCI, Mild cognitive impairment

Values are presented as numbers (%)

^‡p-value for the between-group comparison using Fisher’s exact test